Unknown

Dataset Information

0

Integrated treatment guided by RNA-seq-based endometrial receptivity assessment for infertility complicated by MEN1.


ABSTRACT:

Background

Preimplantation genetic testing (PGT) serves as a tool to avoid genetic disorders in patients with known genetic conditions. However, once a selected embryo is transferred, implantation success is attained independent of embryo quality. Using PGT alone is unable to tackle implantation failure caused by endometrial receptivity (ER) abnormalities in these patients.

Methods

We validated our newly developed RNA-seq-based ER test (rsERT) in a retrospective cohort study including 511 PGT cycles and reported experience in treating an infertile female patient complicated by multiple endocrine neoplasia type 1 (MEN1).

Results

Significant improvement in the clinical pregnancy rate was found in the performed personalized embryo transfer (pET) group (CR, 69.7%; P = 0.035). In the rare MEN1 case, pET was done according to the prediction of the optimal time of window of implantation after unaffected blastocysts were obtained by PGT-M, which ultimately led to a healthy live birth. However, none of the mRNA variants identified in the patient showed a strong association with the MEN1 gene.

Conclusions

Applying the new rsERT along with PGT improved ART outcomes and brought awareness of the importance of the ER examination in MEN1 infertile female patients. MEN1-induced endocrine disorder rather than MEN1 mutation contributes to the ER abnormality.

Trial registration

Reproductive Medicine Ethics Committee of Xiangya Hospital Registry No.: 2022010.

SUBMITTER: Huang X 

PROVIDER: S-EPMC10623411 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integrated treatment guided by RNA-seq-based endometrial receptivity assessment for infertility complicated by MEN1.

Huang Xi X   Fu Jing J   Zhang Qiong Q   Zhao Jing J   Yao Zhongyuan Z   Xia Qiuping Q   Tang Hongying H   Xu Aizhuang A   He Aihua A   Liang Shaolin S   Lu Sijia S   Li Yanping Y  

Frontiers in endocrinology 20231020


<h4>Background</h4>Preimplantation genetic testing (PGT) serves as a tool to avoid genetic disorders in patients with known genetic conditions. However, once a selected embryo is transferred, implantation success is attained independent of embryo quality. Using PGT alone is unable to tackle implantation failure caused by endometrial receptivity (ER) abnormalities in these patients.<h4>Methods</h4>We validated our newly developed RNA-seq-based ER test (rsERT) in a retrospective cohort study inclu  ...[more]

Similar Datasets

| S-EPMC9634259 | biostudies-literature
| S-EPMC10628506 | biostudies-literature
| S-EPMC10688984 | biostudies-literature
| S-EPMC6879696 | biostudies-literature
2009-09-22 | GSE13027 | GEO
| S-EPMC7456953 | biostudies-literature
| S-EPMC9459090 | biostudies-literature
| S-EPMC6617448 | biostudies-literature
| S-EPMC11011295 | biostudies-literature
| S-EPMC8045472 | biostudies-literature